We are live on
!
Find out more
MMRF
Michelson Medical Research Foundation Portfolio holdings
AUM
$108M
1-Year Est. Return
29.95%
This Fund
S&P 500
This Quarter
Est. Return
+12.81%
1 Year Est. Return
+29.95%
3 Year Est. Return
+52.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$108M
AUM Growth
+$9.72M
(+9.9%)
Cap. Flow
-$618K
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
72.13%
Holding
23
New
2
Increased
–
Reduced
–
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$10.8M |
| 2 |
Builders FirstSource
BLDR
|
+$7.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vail Resorts
MTN
|
+$11M |
| 2 |
UnitedHealth
UNH
|
+$8.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.83% |
| 2 | Industrials | 8.02% |
| 3 | Communication Services | 6.4% |
| 4 | Consumer Discretionary | 6.39% |
| 5 | Real Estate | 4.32% |
Similar funds
SA
BC
SF
UFA
YEPX
YAIA
BCM
RRA
Michelson Medical Research Foundation's Q2 2026 Portfolio in Review
As of Q2 2026, Michelson Medical Research Foundation held 23 positions worth $108M, up 9.9% from $98.5M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Michelson Medical Research Foundation's Q2 2026 filing shows 2 new and 2 closed positions. Its largest new stake was CME Group: 39,000 shares worth $8.61M. The largest sale was Vail Resorts, an estimated $11M.
By sector, the portfolio is most concentrated in Financials at 9.8% of assets, up from 2% a quarter earlier, followed by Industrials and Communication Services.
- Michelson Medical Research Foundation's largest Q2 2026 buy was CME Group: 39,000 shares worth $8.61M.
- Michelson Medical Research Foundation fully exited Vail Resorts in Q2 2026, selling an estimated $11M.
- Michelson Medical Research Foundation's ten largest holdings make up 72% of its $108M portfolio in Q2 2026.
- Michelson Medical Research Foundation opened 2 new positions and closed 2 in Q2 2026.
- Michelson Medical Research Foundation's portfolio value rose 9.9% quarter-over-quarter to $108M.
Based on Michelson Medical Research Foundation's 13F filing for Q2 2026, filed 14 Aug 2026.